V. Conde

Ferro (United States) — United States

Medicine · Health Sciences

6h-index221citations42works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(13), Cancer Treatment and Pharmacology(8), Gastric Cancer Management and Outcomes(6), Cholangiocarcinoma and Gallbladder Cancer Studies(6), Hepatocellular Carcinoma Treatment and Prognosis(4)

Publications42 total

Semen Analysis Accuracy and Consequences on Therapeutic Decisions
2025Open Access
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
Scientific Reports·2021· 11 citedOpen Access
Unusual long survival in a case of heterotaxy and polysplenia
Surgical and Radiologic Anatomy·2020· 5 cited
Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy
Cancers·2020· 20 citedOpen Access
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
British Journal of Cancer·2019· 2 citedOpen Access
Clinical significance of BRAF mutations in colorectal cancer: A retrospective study of one institution in a real-life population
Annals of Oncology·2019· 1 cited
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Clinical & Translational Oncology·2018Open Access
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Clinical & Translational Oncology·2017· 4 cited
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial
Annals of Oncology·2017· 13 citedOpen Access
Experience with aflibercept as a second line chemotherapy in metastatic colorectal cancer: Safety and efficacy in a real-life population
Annals of Oncology·2017· 3 citedOpen Access
Analysis retrospective from efficacy with TAS-102 in patients with metastatic colorectal cancer refractory: Experience at two hospitals
Annals of Oncology·2017
Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism
Expert Reviews in Molecular Medicine·2017· 36 cited
P-142 Experience with Aflibercept as a second line chemotherapy in metastatic colorectal cancer
Annals of Oncology·2016Open Access
Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.
Journal of Clinical Oncology·2016· 2 cited
P-266 Aflibercept as a second line chemotherapy in metastatic colorectal cancer. One centre experience
Annals of Oncology·2015· 1 cited
P-124 Clinical outcome and impact of lymph node level assessment in biliary tract cancers
Annals of Oncology·2015Open Access
P-133 Carcinoma of the amulla of vater: factors predictive of survival
Annals of Oncology·2015
P-089 Treatment of metastatic gastric cancer with docetaxel-irinotecan combination: Virgen de las Nieves University Hospital experience
Annals of Oncology·2015Open Access
P-236 Other RAS mutations incidence in CRCm in routine clinical practice: a center experience
Annals of Oncology·2015
Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02
Cancer Chemotherapy and Pharmacology·2014· 17 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Encarnación González‐Flores(20), Juan Ramón Delgado(12), Raquel Luque(10), Joaquina Martínez-Galán(8), Beatriz González-Astorga(8), C. Sánchez-Toro(6), P. Ballesteros(6), Enrique Aranda(5), Julia Ruiz‐Vozmediano(5), Javier Valdivia(5), Antonio Irigoyen López(5), José Antonio Ortega(5), Javier Garcı́a-Garcı́a(4), Bartomeu Massutí(4), Javier Sastre(4), Manuel Valladares‐Ayerbes(4), F. Carabantes(4), Manuel Ruíz‐Borrego(4), José Prados(4), Javier Garcı́a Garcı́a(4)